Carpenter Keri L H, Challis Iain R, Arends Mark J
University of Cambridge, Department of Pathology, UK.
FEBS Lett. 2003 Oct 9;553(1-2):145-50. doi: 10.1016/s0014-5793(03)01007-x.
Death of macrophages and smooth muscle cells (SMC) can lead to progression of atherosclerosis. Mildly oxidised low-density lipoprotein (mildly-oxLDL) induced more overall death and apoptosis than moderately oxidised LDL, in human monocyte-macrophages (HMM). Mildly-oxLDL also induced more overall death in human SMC than did moderately-oxLDL. Mildly-oxLDL contained more hydroperoxides, but less oxysterol, malondialdehyde and negative charge than moderately-oxLDL. Specific inhibition of lipoprotein-associated phospholipase A(2) (by SB222657) diminished death induction in HMM by both oxLDL types. Peroxisome proliferator-activated receptor gamma (PPARgamma) antagonist (GW9662) and agonist (ciglitazone) experiments suggested that non-hydrolysed, oxidised phospholipids in oxLDL activate PPARgamma as a cellular defence mechanism. These results may be relevant to LDL oxidation within atherosclerotic plaques and may suggest strategies for combating atherosclerosis progression.
巨噬细胞和平滑肌细胞(SMC)的死亡会导致动脉粥样硬化的进展。在人类单核细胞 - 巨噬细胞(HMM)中,轻度氧化的低密度脂蛋白(轻度氧化型低密度脂蛋白,mildly-oxLDL)比中度氧化的低密度脂蛋白诱导更多的总体死亡和凋亡。轻度氧化型低密度脂蛋白在人类SMC中也比中度氧化型低密度脂蛋白诱导更多的总体死亡。与中度氧化型低密度脂蛋白相比,轻度氧化型低密度脂蛋白含有更多的氢过氧化物,但氧化甾醇、丙二醛和负电荷较少。脂蛋白相关磷脂酶A2的特异性抑制(通过SB222657)减少了两种氧化型低密度脂蛋白对HMM的死亡诱导。过氧化物酶体增殖物激活受体γ(PPARγ)拮抗剂(GW9662)和激动剂(吡格列酮)实验表明,氧化型低密度脂蛋白中未水解的氧化磷脂作为一种细胞防御机制激活PPARγ。这些结果可能与动脉粥样硬化斑块内的低密度脂蛋白氧化有关,并可能提示对抗动脉粥样硬化进展的策略。